FreeO2 automatically and continuously adapts the oxygen flow rate delivered to the patient, taking into account the patient’s needs and dynamics, with the aim of respecting the target SpO2 defined by the clinician.
FreeO2 operates on a closed-loop principle. Supplied by an oxygen source, it continuously measures the oxygen saturation (SpO2) of the patient and adjusts the O2 flow rate that is administered in a rapid and precise way until complete weaning.
Reduction of risk of patient/staff cross contamination
Reduction of Costs of PPE’s not having to go in a room just to adjust O2
Reduction in time spent donning and doffing PPE, freeing up staff to perform more important tasks
Safer and more clinically effective oxygen therapy
Improved compliance with clinical recommendations and fewer complications related to hypoxemia and hyperoxia
• Safer and more clinically effective oxygen therapy
• Improved compliance with clinical recommendations and fewer complications related to hypoxemia and hyperoxia
• Significant reductions in hospital length of stay and cost of care
Tested on patients hospitalized for an exacerbation of COPD, FreeO2 has made it possible to reduce the length of hospital stays by around 30% (6.7 days compared with 9.5 days).
On the basis of this clinical study a medico-economic study taking into consideration the total of hospital costs at 180 days found an overall reduction of costs of care of around 21% per COPD patient.
Used in the emergency room to care for acute respiratory distress, FreeO2 makes it possible to treat patients more effectively (assessed according to the time spent by the patient at the target SpO2), to limit complications related to hypoxia and hyperoxia, to wean certain patients more quickly, and to avoid transferring patients to intensive care. Moreover, the study data points to a reduction in the workload of healthcare staff and greater compliance with clinical protocol.
For freeO2, yes, it is well established and well-integrated by my team. They feel comfortable with the devices. They are often used in patients who develop post covid fibrosis. It works really well, and the weaning time has really improved a lot.
Edith, Hopital du Haut-Richelieu, St-Jean-sur-Richelieu.
© [2020 All Rights Reserved] — Novus Medical Inc.
